These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. Ronco P; Debiec H Lancet; 2015 May; 385(9981):1983-92. PubMed ID: 26090644 [TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of membranous nephropathy: evolution and revolution. Glassock RJ Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552 [TBL] [Abstract][Full Text] [Related]
16. [Membranous nephropathy: up to date]. Imai E Nihon Jinzo Gakkai Shi; 2011; 53(5):692-6. PubMed ID: 21842602 [No Abstract] [Full Text] [Related]
17. [Membranous nephropathy: New insights in therapeutic approach]. Dahan K Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748 [TBL] [Abstract][Full Text] [Related]
18. Membranous nephropathy: recent travels and new roads ahead. Beck LH; Salant DJ Kidney Int; 2010 May; 77(9):765-70. PubMed ID: 20182413 [TBL] [Abstract][Full Text] [Related]
19. Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies. Brenchley PE J Am Soc Nephrol; 2015 Oct; 26(10):2308-11. PubMed ID: 25804283 [No Abstract] [Full Text] [Related]